Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10912833 Delivery of negatively charged proteins using cationic lipids

Patent 10912833 was granted and assigned to President and Fellows of Harvard College on February, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
‌
President and Fellows of Harvard College
Date Filed
April 20, 2018
Date of Patent
February 9, 2021
Patent Applicant
‌
President and Fellows of Harvard College
Patent Application Number
15958721
Patent Citations
‌
US Patent 10113163 Adenosine nucleobase editors and uses thereof
0
‌
US Patent 10167457 Nucleobase editors and uses thereof
‌
US Patent 10227581 Engineered transcription activator-like effector (TALE) domains and uses thereof
0
‌
US Patent 10323236 Evaluation and improvement of nuclease cleavage specificity
‌
US Patent 10465176 Cas variants for gene editing
‌
US Patent 10597679 Switchable Cas9 nucleases and uses thereof
0
‌
US Patent 10508298 Methods for identifying a target site of a CAS9 nuclease
‌
US Patent 10682410 Delivery system for functional nucleases
‌
US Patent 10704062 CAS9 proteins including ligand-dependent inteins
‌
US Patent 10745677 Editing of CCR5 receptor gene to protect against HIV infection
•••
Patent Citations Received
‌
US Patent 12084663 Incorporation of unnatural amino acids into proteins using base editing
0
‌
US Patent 11542509 Incorporation of unnatural amino acids into proteins using base editing
‌
US Patent 11560566 Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
0
‌
US Patent 11920181 Nuclease profiling system
0
‌
US Patent 11932884 High efficiency base editors comprising Gam
0
‌
US Patent 11999947 Adenosine nucleobase editors and uses thereof
0
‌
US Patent 12006520 Evaluation and improvement of nuclease cleavage specificity
0
‌
US Patent 11542496 Cytosine to guanine base editor
‌
US Patent 11578343 CAS9 proteins including ligand-dependent inteins
0
‌
US Patent 11046948 Engineered transcription activator-like effector (TALE) domains and uses thereof
0
•••
Patent Inventor Names
John Anthony Zuris
0
David B. Thompson
0
David R. Liu
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10912833
Patent Primary Examiner
‌
Kagnew H Gebreyesus

Find more entities like US Patent 10912833 Delivery of negatively charged proteins using cationic lipids

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo